US-based developer of ultrasound tools Fujifilm SonoSite has secured CE mark and 510(k) clearance for its new mountable ultrasound system, the SonoSite SII.
The technology can be utilised for regional anesthesia, vascular access and trauma applications and enables the physicians to better perform leveraging on its simple user interface that can be tailored to the user’s imaging needs.
Go deeper with GlobalData
It can be used across different hospitals, including a zero footprint option for space-constrained rooms.
Fujifilm SonoSite global direct sales vice-president Brian Leck said: "The new SII ultrasound system expands on the design goals of our mountable legacy system by offering more functionality and an even better user experience from start to finish.
"We listened to clinicians, and delivered a product designed to maximise the efficiency of their ultrasound use.
"The SII captures the epitome of the SonoSite brand, allowing clinicians to confidently use the system from day one."
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe SII features a new touchscreen user interface with a clinician-driven menu logic which can adjust to the situational cases, particularly for the regional anesthesiologists as they perform an increasing number of ultrasound-guided procedures every day.
It consists of an embedded dual transducer connector which enables a quick change between transducers with two taps of the screen, ensuring that the right transducer is always readily available.
The SII is also fitted with a new stand, offering elevated transducer holders and additional storage to speed the whole procedure.
SII leverages on its DirectClear technology, a novel, patent-pending process that is available on select transducers.
It is instrumental for trauma patients for who speed and ease of image acquisition is essential to shape the course of treatment.
The DirectClear elevates transducer performance by increasing penetration and contrast resolution. This transducer innovation contributes to an unsurpassed imaging experience for the clinician.
